메뉴 건너뛰기




Volumn 11, Issue 8, 2008, Pages 26-29

Understanding the pain: Managing severe PMS

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

EID: 52649096857     PISSN: 14613123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)

References (10)
  • 2
    • 0034734709 scopus 로고    scopus 로고
    • Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
    • 30; 356 9236
    • Dimmock P W, Wyatt K M, Jones P W and O'Brien P M (2000). 'Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review'. The Lancet, 30; 356 (9236): 1131-6.
    • (2000) The Lancet , pp. 1131-1136
    • Dimmock, P.W.1    Wyatt, K.M.2    Jones, P.W.3    O'Brien, P.M.4
  • 3
    • 0036597591 scopus 로고    scopus 로고
    • Citalopram in PMS patients with prior SSRI treatment failure: A preliminary study
    • Freeman E W, Jabara S, Sondheimer S J and Auletto R (2002). 'Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study' J Women's Health Gend Based Med, 11 (5): 459-64.
    • (2002) J Women's Health Gend Based Med , vol.11 , Issue.5 , pp. 459-464
    • Freeman, E.W.1    Jabara, S.2    Sondheimer, S.J.3    Auletto, R.4
  • 4
    • 0034865958 scopus 로고    scopus 로고
    • Freeman E W, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, Zhang P, Patel H and Foegh M (PMS/PMDD Research Group) (2001). 'Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder'. J Worn Health Gend Based Med, 10: 561-9.
    • Freeman E W, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, Zhang P, Patel H and Foegh M (PMS/PMDD Research Group) (2001). 'Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder'. J Worn Health Gend Based Med, 10: 561-9.
  • 6
    • 0028924777 scopus 로고
    • A randomised, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome
    • Hahn P M, Van Vugt D A and Reid R L (1995). 'A randomised, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome'. Psychoneuroendocrinology, 20: 193-209.
    • (1995) Psychoneuroendocrinology , vol.20 , pp. 193-209
    • Hahn, P.M.1    Van Vugt, D.A.2    Reid, R.L.3
  • 7
    • 0036711324 scopus 로고    scopus 로고
    • A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder
    • Hunter M S, Ussher J M, Browne S J, Cariss M, Jelley R and Katz M (2002). 'A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder'. J Psychosom Obstet Gynaecol, 23 (3): 193-9.
    • (2002) J Psychosom Obstet Gynaecol , vol.23 , Issue.3 , pp. 193-199
    • Hunter, M.S.1    Ussher, J.M.2    Browne, S.J.3    Cariss, M.4    Jelley, R.5    Katz, M.6
  • 8
    • 34248329904 scopus 로고    scopus 로고
    • Management of severe premenstrual syndrome
    • and, eds, Part III pp181-196
    • Ng C, Cloke B and Panay N (2002). 'Management of severe premenstrual syndrome', in J Barter and N Hampton (eds) (2002), The Year in Obstetrics & Gynaecology, Part III pp181-196.
    • (2002) The Year in Obstetrics & Gynaecology
    • Ng, C.1    Cloke, B.2    Panay, N.3
  • 9
    • 0030766585 scopus 로고    scopus 로고
    • Progestogen intolerance and compliance with hormone replacement therapy in menopausal women
    • Panay N and Studd J (1997). 'Progestogen intolerance and compliance with hormone replacement therapy in menopausal women'. Hum Reprod Update, 3: 159-71.
    • (1997) Hum Reprod Update , vol.3 , pp. 159-171
    • Panay, N.1    Studd, J.2
  • 10
    • 0029027163 scopus 로고
    • A randomised comparison over 8 months of 100mg and 200mg twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome
    • Smith R N J, Studd J W W, Zamblera D and Holland EF (1995). 'A randomised comparison over 8 months of 100mg and 200mg twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome'. Br J Obstet Gynaecol, 102: 475-84.
    • (1995) Br J Obstet Gynaecol , vol.102 , pp. 475-484
    • Smith, R.N.J.1    Studd, J.W.W.2    Zamblera, D.3    Holland, E.F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.